Northwest Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-219
Closed -$181K 406
2025
Q1
$181K Hold
219
0.07% 121
2024
Q4
$169K Buy
219
+19
+10% +$15.7K 0.07% 118
2024
Q3
$177K Hold
200
0.06% 114
2024
Q2
$181K Sell
200
-28
-12% -$22.4K 0.07% 113
2024
Q1
$177K Hold
228
0.06% 137
2023
Q4
$133K Sell
228
-6
-3% -$3.5K 0.04% 154
2023
Q3
$126K Hold
234
0.05% 147
2023
Q2
$110K Buy
+234
New +$98.1K 0.05% 153

Other funds holding LLY

Northwest Capital Management's LLY Position: Q2 2025 in Review

Northwest Capital Management sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 219 shares — an estimated $181K sold.

Northwest Capital Management first reported a position in LLY in Q2 2023 and held it in 8 quarters. The position peaked at $181K in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Northwest Capital Management reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Northwest Capital Management sold 219 Eli Lilly shares in Q2 2025, an estimated $181K.
  • Northwest Capital Management first reported a position in Eli Lilly in Q2 2023 and held it in 8 quarters.
  • Northwest Capital Management's Eli Lilly position peaked at $181K in Q2 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Northwest Capital Management's 13F filing for Q2 2025, filed 25 Jul 2025.